semaglutide and cagrilintide VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity Type 2 Diabetes Semaglutide, a glucagon-like peptide-1 (GLP-1)

It is FDA-approved for adults with obesity (a Body Mass Index, or BMI, of 30 or more) or those who are overweight (a BMI of 27 or more) and have at least one weight-related health condition, such as high blood pressure or type 2 diabetes

Rx only References Bohmer, T., Rydning, A

Sikiric, P., Udovicic, M., Barisic, I., Balenovic, D., Zivanovic Posilovic, G., Strinic, D., Uzun, S., Sikiric, S., Krezic, I., Zizek, H., Yago, H., Gojkovic, S., Smoday, I

This typically includes: Comprehensive hormone and metabolic assessment Bioidentical hormone therapy (customized dosing) Metabolic support (GLP-1s when appropriate, peptides, supplementation) Ongoing monitoring and dose adjustment Nutritional guidance and exercise programming Integration with aesthetic treatments as desired Most Chicago women find that the improvement in energy, cognitive function, professional performance, and quality of life makes this one of the highest-ROI health investments they make

These statements have not been evaluated by the Food and Drug Administration